Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock

🌐 Investing.com (Cyprus) —
Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock

AI Summary

Opaleye Management, a 10% owner of Grace Therapeutics, bought $123,819 worth of the company’s stock. The purchase is a disclosed insider or major-shareholder transaction.

Markets Opaleye Management Grace Therapeutics stock purchase shareholder biotechnology

Read original source →